The research of Sidney Kimmel Cancer Center investigator Veda Giri, MD, has been highlighted on the Congressionally Directed Medical Research Programs (CDMRP) website.
Giri and her team received funding from the U.S. Department of Defense Prostate Cancer Research Program (PCRP) to conduct studies on men at high risk for aggressive prostate cancer. She and her team found that certain genetic markers on chromosome arms 8q and 17q are predictive for an earlier diagnosis of prostate cancer, thus helping to identify those men that might benefit from more proactive screening, treatment, and genetic counseling.
Giri is Director of Cancer Risk Assessment and Clinical Cancer Genetics and Associate Professor in Medical Oncology and Cancer Biology at the Sidney Kimmel Cancer Center at Jefferson. Her research focuses on genetic testing and counseling for men at high risk of developing prostate cancer, and she currently leads a multi-institutional effort to identify genetic variants associated with elevated risk of prostate cancer.
For further information, see: